Navigation Links
Conversion of brain tumor cells into blood vessels thwarts treatment efforts
Date:1/24/2011

LA JOLLA, CA--Glioblastoma, the most common and lethal form of brain cancer and the disease that killed Massachusetts Senator Ted Kennedy, resists nearly all treatment efforts, even when attacked simultaneously on several fronts. One explanation can be found in the tumor cells' unexpected flexibility, discovered researchers at the Salk Institute for Biological Studies.

When faced with a life-threatening oxygen shortage, glioblastoma cells can shift gears and morph into blood vessels to ensure the continued supply of nutrients, reports a team led by Inder Verma, Ph.D., in a feature article in this week's issue of the Proceedings of the National Academy of Sciences.

Their study not only explains why cancer treatments that target angiogenesis--the growth of a network of blood vessels that supplies nutrients and oxygen to cancerous tissues--routinely fail in glioblastoma, but the findings may also spur the development of drugs aimed at novel targets.

"This surprising effect of anti-angiogenic therapy with drugs such as Avastin tells us that we have to rethink glioblastoma combination therapy," says senior author Verma, a professor in the Laboratory of Genetics and holder of the Irwin and Joan Jacobs Chair in Exemplary Life Science. "Disrupting the formation of tumor blood vessels is not enough; we also have to prevent the conversion of tumor cells into blood vessels cells."

To grow beyond one to two millimeters in diameter--roughly the size of a pinhead--tumors need their own independent blood supply. To recruit new vasculature from existing blood vessels, many tumors overexpress growth factors, predominantly vascular endothelial growth factor, or VEGF. This led to the development of Avastin, a monoclonal antibody that intercepts VEGF.

"In a recent phase II clinical trial, 60 percent of patients with glioblastoma responded to a combination of Avastin and Irinotecan, which directly interferes with the growth
'/>"/>

Contact: Gina Kirchweger
Kirchweger@salk.edu
858-453-410-01340
Salk Institute
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Brown University chemists simplify biodiesel conversion
2. Mount Sinai researchers discover new mechanism behind cellular energy conversion
3. New microbial genetic system dissects biomass to biofuel conversion
4. New molecule could save brain cells from neurodegeneration, stroke
5. Reducing diet early in pregnancy stunts fetal brain development
6. New technique to see neurons of the deep brain for months at a time developed at Stanford
7. LCD projector used to control brain and muscles of tiny organisms such as worms
8. Researchers show how Alzheimers plaques lead to loss of nitric oxide in brain
9. New book highlights the cellular and molecular determinants of brain wiring
10. Major advance in MRI allows much faster brain scans
11. UTHealth studies cord blood stem cells for pediatric traumatic brain injury
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Conversion of brain tumor cells into blood vessels thwarts treatment efforts
(Date:6/14/2013)... Cliffs of Dover" was a morale-boosting song that lifted ... mark the point at which England is closest to ... structures made of the chalky, white shells that envelop ... . "Ehux" is a coccolithophore, with an exoskeleton made ... the alga,s "armor" forms releases carbon dioxide, Ehux can ...
(Date:6/14/2013)... 12 June 2013: Data presented at EULAR 2013, the ... that novel antibody biomarkers could significantly improve diagnosis in ... UH-RA.1, UH-RA.9, UH-RA.14 and UH-RA.21 were investigated; as ... were present in both early and seronegative disease, ... and ACCP -negative patients testing positive. , RA ...
(Date:6/13/2013)... that combining improved oyster restoration methods with limits on ... population back to the Bay in a much shorter ... of the University of Maryland Center for Environmental Science,s ... restoration options to see which ones would have the ... we developed suggests that oysters should be able to ...
Breaking Biology News(10 mins):Chalking up a marine blooming alga: Genome fills a gap in the tree of life 2Chalking up a marine blooming alga: Genome fills a gap in the tree of life 3Chalking up a marine blooming alga: Genome fills a gap in the tree of life 4Oysters could rebound more quickly with limited fishing and improved habitat 2
... remains the subject of "best guesses," and as a ... perceptions and politics, rather than an objective assessment of ... , Simon Hay and Robert Snow (Kenya Medical Research ... been almost 40 years since the last global map ...
... be arranged along a ladder of intelligence—a sort of ... by our close relatives, the primates, all the way ... past decade, this ladder has been challenged by claims ... animals. For example, spotted hyenas establish hierarchies in which ...
... fight viruses is also involved in keeping cancer cells alive, ... The anti-viral molecule, called TBK-1, was found to be essential ... to a treatment for fighting cancer, the researchers report in ... surprise that this mechanism is involved in cancer cell survival, ...
Cached Biology News:Fishy cooperation 2Natural anti-viral enzyme helps keep cancer cells alive, researchers find 2
(Date:6/17/2013)... LONDON and BOSTON , June ... market is set to reach $127 billion by 2018, accounting ... to the recently released Orphan Drug Report 2013 ... its clients, needs in regard to this growing segment of ... core product database to include in-depth, fact-based orphan drug analysis ...
(Date:6/17/2013)... June 17, 2013 With the huge success ... of the Chief Medical Officer Summit for Emerging Life Science ... take place in San Francisco on November 4-5, 2013 at ... first time, West Coast Chief Medical Officers at biotechs have ... Stoner, Managing Director of MPM Capital. Valerie Bowling, Executive Director ...
(Date:6/17/2013)... MUNDELEIN, Ill. , June 17, 2013 /PRNewswire/ ... – News), a biotechnology company providing value-added ingredients ... it will be presenting a new meat application ... (IFT) show in Chicago , ... Trim ingredients can replace more expensive/chemically-modified ingredients in ...
(Date:6/17/2013)... DUBLIN , June 17, 2013 /PRNewswire/ ... http://www.researchandmarkets.com/research/9rwvs2/north_america ) has announced the addition of ... Market - by Formulations [Liposomes, Microspheres, & ... Prefilled, Pen, Needle Free & Auto Injectors] ... to their offering. ,      ...
Breaking Biology Technology:Evaluate Launches Enhanced Orphan Drug Intelligence 2Evaluate Launches Enhanced Orphan Drug Intelligence 3Chief Medical Officer Summit for Biotechs Goes West 2Chief Medical Officer Summit for Biotechs Goes West 3Z Trim to Spotlight New Meat Applications at IFT 2013 in Chicago 2Z Trim to Spotlight New Meat Applications at IFT 2013 in Chicago 3North America Injectable Drug Delivery Market - by Formulations, Devices & Therapeutics- Forecasts to 2017 2North America Injectable Drug Delivery Market - by Formulations, Devices & Therapeutics- Forecasts to 2017 3
... N.J., Dec. 17 National Stem,Cell Holding, Inc. ... financial information, quotations and press releases are,posted on ... OTCIQ is a secure, web-based portal that ... facilitate communication with the,marketplace, promote transparency, mitigate risk, ...
... Genzyme Corp.,(Nasdaq: GENZ ) announced today that ... a supplemental indication for Thyrogen(R) (thyrotropin,alfa for injection) ... ablate,or destroy, the remaining thyroid tissue in patients ... is a procedure that patients,commonly undergo when being ...
... DIEGO, Dec. 17 SGX Pharmaceuticals, Inc.,(Nasdaq: SGXP ... appointed to,the company,s Board of Directors. Mr. Turner brings ... and will also serve on,the company,s audit committee., ... said Dr. Christopher S.,Henney, Chairman of the Board of ...
Cached Biology Technology:National Stem Cell Holding, Inc. Posts Company and Financial Information on the OTCIQ and Has Retained New CFO and Counsel to File Registration Statement With SEC 2Genzyme Announces FDA Approval of Thyrogen(R) for Use in Thyroid Cancer Ablation 2Genzyme Announces FDA Approval of Thyrogen(R) for Use in Thyroid Cancer Ablation 3Genzyme Announces FDA Approval of Thyrogen(R) for Use in Thyroid Cancer Ablation 4SGX Pharmaceuticals Appoints Joseph L. Turner to Board of Directors 2SGX Pharmaceuticals Appoints Joseph L. Turner to Board of Directors 3
... IgY Antibodies Hypothetical protein FLJ20644, likely ... Protein Accession #: NP_060387.1 ... Genbank Definition: chromosome 14 open ... phosphatase subunit gene g4-1 [Homo sapiens] ...
Request Info...
Lineage cocktail 1 (lin 1) 50 tests...
Contained in EZ-Tn5™ Kits and are available separately for sequencing of an insertion site....
Biology Products: